Other
CR2O
Total Trials
3
Recruiting
0
Active
1
Completed
1
Success Rate
50.0%-37% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
Failure Rate
33.3%
1 terminated/withdrawn out of 3 trials
Success Rate
50.0%
-36.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed trials have results
Key Signals
1 with results
Enrollment Performance
Analytics
Phase 2
1(33.3%)
Early Phase 1
1(33.3%)
Phase 1
1(33.3%)
3Total
Phase 2(1)
Early Phase 1(1)
Phase 1(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (3)
Showing 3 of 3 trials
NCT06975319Early Phase 1Active Not Recruiting
Phase I Study With V-212 Vaccinations in Healthy Adult Volunteers
Role: collaborator
NCT04119440Phase 1Completed
Safety and Immunogenicity of the Candidate Vaccine MVA-MERS-S_DF-1 Against MERS
Role: collaborator
NCT02888756Phase 2Terminated
iHIVARNA Clinical Trial in HIV Infected Individuals
Role: collaborator
All 3 trials loaded